Studies point to Johnson & Johnson, Pfizer and Bharat Biotech’s vaccines neutralizing the Delta variant of SARS-CoV-2, even if efficacy is lower compared to the original strain. This follows positive news from other vaccine companies but will the Lambda variant cause a setback?

Former FDA chief Kessler heads CSPI board; CRN-supported Rose Awards go to Ross, Das; Bobbie Baby infant formula fails FDA standards; CRN launches Retailer Relations Forum; and NAI alleges CarnoSyn trademark infringement by Vitalize.

Listings for more thazn 27,000 Plant Devas' evanhealy products are included in the latest update to FDA's database of regulated-product recalls that haven started by marketers or manufacturers and assigned a classification of urgency level, posted March 21.

Warning letter and multiple form 483s fail to convince Custompax; Kellogg acquires RXBAR clean-label protein bars for $600m; NutraFuels used Blast Cap for products; and more news in brief.